Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254669 · ClinicalTrials.gov registry record · NA
An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01254669 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT01254669, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV vaccine with parents of Black adolescent girls being less likely to accept and comply with HPV immunization schedules than Whites. The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. The investigator's hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.
Interventions
- BEHAVIORAL BNI-brief Negotiated Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01254669
The ClinicalTrials.gov registry entry for NCT01254669 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BNI-brief Negotiated Interview is the first listed.
NCT01254669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01254669 about?
NCT01254669 is a clinical study titled "An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls". In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV va...
What is the current status of trial NCT01254669?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2011-01. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01254669?
The interventions under investigation include: BNI-brief Negotiated Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT01254669?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.